This podcast episode provided an oncology news roundup focusing on 4 updates related to non-small cell lung cancer treatment. It discussed the role of pharmacists in chemotherapy management for NSCLC patients and barriers like insurance coverage. It also reviewed two recent FDA drug approvals for advanced NSCLC and results from a phase 3 trial that did not meet its primary endpoint. The podcast aimed to break down the latest news in the oncology pharmacy space for listeners.